PLLA Coating of Lyophilized Human Bone Allograft for Long-term Release of Antibiotics
Based on these results, future optimization can focus on selecting more efficient release of antibiotics and increasing the encapsulated concentration to sustain antibiotic release over 4 months, thereby improving the bacteriostatic effect <i>in vivo</i>. Furthermore, biocompatibility and osteoconductivity must be improved.
Authors
- Milena Radenković (ORCID: https://orcid.org/0000-0003-0603-0684)
- Florian Beuer (ORCID: https://orcid.org/0000-0003-0246-790X)
- Sanja Stojanović (ORCID: https://orcid.org/0000-0002-6560-6762)
- Stevo Najman (ORCID: https://orcid.org/0000-0002-2411-9802)
- Ole Jung (ORCID: https://orcid.org/0000-0001-8005-2916)
- Xin Xiong (ORCID: https://orcid.org/0000-0003-0902-7886)
- Mike Barbeck (ORCID: https://orcid.org/0000-0002-3001-1347)
- Jiawei Zhang (ORCID: https://orcid.org/0000-0002-3534-6103)
- Anne Foth
Institutions
- University of Nis (RS)
- Natural and Medical Sciences Institute (DE)
- Berlin Institute of Health at Charité - Universitätsmedizin Berlin (DE)
- University of Rostock (DE)
- University of Tübingen (DE)
Publication Details
- Journal
- In Vivo
- Published
- 2025-06-27
- DOI
- https://doi.org/10.21873/invivo.13987
- Citations
- 2
- Primary Topic
- Orthopedic Infections and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 4.01
Funders
- Deutsche Forschungsgemeinschaft
- Bundesministerium für Bildung und Forschung